Journal
Clinical Ophthalmology
Publication Date
1-1-2021
Volume
15
First Page
79
Last Page
91
Document Type
Open Access Publication
DOI
10.2147/OPTH.S278169
Rights and Permissions
Pepose JS, Hartman PJ, DuBiner HB, Abrams MA, Smyth-Medina RJ, Moroi SE, Meyer AR, Sooch MP, Jaber RM, Charizanis K, Klapman SA, Amin AT, Yousif JE, Lazar ES, Karpecki PM, Slonim CB, McDonald MB. Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial. Clin Ophthalmol. 2021 Jan 8;15:79-91. doi.org/10.2147/OPTH.S278169 This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended Citation
Pepose, Jay S and et al, "Phentolamine mesylate ophthalmic solution provides lasting pupil modulation and improves near visual acuity in presbyopic glaucoma patients in a randomized Phase 2b clinical trial." Clinical Ophthalmology. 15, 79 - 91. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11537
